114 related articles for article (PubMed ID: 38468944)
1. DNA methylation characteristics associated with chemotherapy resistance in epithelial ovarian cancer.
Duan C; Yan Z; Wu C; Zhou X; Bao W
Heliyon; 2024 Mar; 10(5):e27212. PubMed ID: 38468944
[TBL] [Abstract][Full Text] [Related]
2. Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer.
Feng LY; Yan BB; Huang YZ; Li L
Clin Epigenetics; 2021 Jul; 13(1):141. PubMed ID: 34289901
[TBL] [Abstract][Full Text] [Related]
3. Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy.
Bachvarov D; L'esperance S; Popa I; Bachvarova M; Plante M; Têtu B
Int J Oncol; 2006 Oct; 29(4):919-33. PubMed ID: 16964388
[TBL] [Abstract][Full Text] [Related]
4. A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer.
Zhao L; Ma S; Wang L; Wang Y; Feng X; Liang D; Han L; Li M; Li Q
Mol Ther Oncolytics; 2021 Mar; 20():545-555. PubMed ID: 33738340
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis.
Sun Y; Yao L; Wang C; Xiong B; Guo J; Wang L; Zhu J; Cheng Z; Liu S
J Oncol; 2022; 2022():6406122. PubMed ID: 35401749
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.
Huang H; Li Y; Liu J; Zheng M; Feng Y; Hu K; Huang Y; Huang Q
PLoS One; 2012; 7(12):e51256. PubMed ID: 23251472
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
Shuang T; Wang M; Zhou Y; Shi C
Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
[TBL] [Abstract][Full Text] [Related]
8. Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer.
Wang B; Yu L; Luo X; Huang L; Li QS; Shao XS; Liu Y; Fan Y; Yang GZ
Oncol Lett; 2017 Jul; 14(1):217-223. PubMed ID: 28693156
[TBL] [Abstract][Full Text] [Related]
9. Specific point mutations in key redox enzymes are associated with chemoresistance in epithelial ovarian cancer.
Fletcher NM; Belotte J; Saed MG; Memaj I; Diamond MP; Morris RT; Saed GM
Free Radic Biol Med; 2017 Jan; 102():122-132. PubMed ID: 27890641
[TBL] [Abstract][Full Text] [Related]
10. Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin.
Gerber E; Asare-Werehene M; Reunov A; Burger D; Le T; Carmona E; Mes-Masson AM; Tsang BK
J Ovarian Res; 2023 Jan; 16(1):14. PubMed ID: 36642715
[TBL] [Abstract][Full Text] [Related]
11. A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer.
Li DH; Du XH; Liu M; Zhang R
Cancer Genet; 2021 Apr; 252-253():80-86. PubMed ID: 33444882
[TBL] [Abstract][Full Text] [Related]
12. Epigenome-wide DNA methylation profiling of preeclamptic placenta according to severe features.
Lim JH; Kang YJ; Bak HJ; Kim MS; Lee HJ; Kwak DW; Han YJ; Kim MY; Boo H; Kim SY; Ryu HM
Clin Epigenetics; 2020 Aug; 12(1):128. PubMed ID: 32831145
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer.
Li M; Balch C; Montgomery JS; Jeong M; Chung JH; Yan P; Huang TH; Kim S; Nephew KP
BMC Med Genomics; 2009 Jun; 2():34. PubMed ID: 19505326
[TBL] [Abstract][Full Text] [Related]
14. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
[TBL] [Abstract][Full Text] [Related]
15. CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target.
Feng X; Bai X; Ni J; Wasinger VC; Beretov J; Zhu Y; Graham P; Li Y
Front Oncol; 2019; 9():557. PubMed ID: 31380263
[No Abstract] [Full Text] [Related]
16. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide differential methylation analyses identifies methylation signatures of male infertility.
Sujit KM; Sarkar S; Singh V; Pandey R; Agrawal NK; Trivedi S; Singh K; Gupta G; Rajender S
Hum Reprod; 2018 Dec; 33(12):2256-2267. PubMed ID: 30358834
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of nuclear NF-κB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer.
Shuang T; Wang M; Zhou Y; Shi C
Exp Mol Pathol; 2016 Feb; 100(1):139-44. PubMed ID: 26683819
[TBL] [Abstract][Full Text] [Related]
19. Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma.
Bonneau C; Rouzier R; Geyl C; Cortez A; Castela M; Lis R; Daraï E; Touboul C
Gynecol Oncol; 2015 Jan; 136(1):112-20. PubMed ID: 25449309
[TBL] [Abstract][Full Text] [Related]
20. Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.
Zeller C; Dai W; Steele NL; Siddiq A; Walley AJ; Wilhelm-Benartzi CS; Rizzo S; van der Zee A; Plumb JA; Brown R
Oncogene; 2012 Oct; 31(42):4567-76. PubMed ID: 22249249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
